GE Healthcare and Medipattern confirmed their plans to collaborate by signing a definitive collaboration agreement. Medipattern will leverage technology developed in its Cadenza algorithm platform and extend it with additional functionality to create vascular imaging quantification tools.
Medipattern will leverage technology developed in its Cadenza(TM) algorithm platform and extend it with additional functionality to create Vascular iQ. Medipattern will create a generalized version of the vascular product while building an exclusive version for GE Healthcare ultrasound systems, which will be available to the market through GE’s well-established distribution to clinicians around the world.
Michael Arbaugh, GE Healthcare general manager of GE Healthcare’s Vascular Ultrasound division, said: GE Healthcare’s Vascular Ultrasound team is committed to developing new technology to image and analyze vascular disease, increasing diagnostic confidence, and speeding patient treatment. Our investment in dedicated vascular expertise, support of vascular education, and unique vascular technologies are evidence of this commitment. GE is actively developing new ultrasound products to capture distinctive diagnostic images.
Medipattern has proven to be a valued partner and we have invited them to join us in our goal to raise analytical understanding of vascular disease. We believe that Medipattern’s technology will be very beneficial to improving the outlook for those patients with vascular disease, said the company